Krux Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 3.00 Cr
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.77 Cr
- Satisfied Charges ₹ 31.49 Cr
- Revenue Growth 45.11%
- Profit Growth -12.94%
- Ebitda 15.19%
- Net Worth 2.42%
- Total Assets 5.38%
About Krux Pharma
Krux Pharma Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 October 2016 (Eight years and four months 26 days old ). Its registered office is in Valsad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹11.77 Cr. The company has closed loans amounting to ₹31.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
Salim Chopdar and Imran Siroha serve as directors at the Company.
Company Details
- Location
Valsad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24302GJ2016PTC094103
- Company No.
094103
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2016
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
Krux Pharma Private Limited
Explore comprehensive data for Krux Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Krux Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Salim Chopdar  | Director | 18-Mar-2024 | Current |
| Imran Siroha | Director | 17-Oct-2016 | Current |
Financial Performance of Krux Pharma.
Krux Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 45.11% increase. The company also saw a substantial fall in profitability, with a 12.94% decrease in profit. The company's net worth moved up by a moderate rise of 2.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krux Pharma?
In 2024, Krux Pharma had a promoter holding of 33.33% and a public holding of 66.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rajasthan Aushdhalaya Private LimitedSalim Chopdar is a mutual person
Charges (Loans)
Open Charges
₹11.77 Cr
Satisfied Charges
₹31.49 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 11.77 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Aug 2023 | Yes Bank Limited | ₹11.77 Cr | Open |
| 03 Jul 2021 | Hdfc Bank Limited | ₹11.59 Cr | Satisfied |
| 09 Oct 2018 | Indian Bank | ₹9.95 Cr | Satisfied |
| 05 Oct 2018 | Indian Bank | ₹9.95 Cr | Satisfied |
How Many Employees Work at Krux Pharma?
Krux Pharma has a workforce of 42 employees as of Feb 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krux Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krux Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Krux Pharma
Recent activity within the organization
- Annual General Meeting
Krux Pharma Private Limited last Annual general meeting of members was held on 16 Sep 2024 as per latest MCA records.
- Balance Sheet
Krux Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
- Charges
A charge with Yes Bank Limited of Rs. 11.77 Cr registered on 25 Aug 2023 with Charge ID 100790704 was modified on 20 Mar 2024.
- Director Appointment
Salim Diwan Salaudeen Chopdar was appointed as a Director was appointed as a Director on 18 Mar 2024 & has been associated with this company since 11 months 25 days .
- Charges
A charge registered on 03 Jul 2021 via Charge ID 100458144 with Hdfc Bank Limited was fully satisfied on 03 Nov 2023.
- Charges
A charge with Yes Bank Limited amounted to Rs. 11.77 Cr with Charge ID 100790704 was registered on 25 Aug 2023.
Frequently asked questions
What is the Incorporation or founding date of Krux Pharma Private Limited?
Krux Pharma Private Limited was incorporated on 17 Oct 2016.
What is authorized share capital and paid-up capital of Krux Pharma Private Limited?
The authorized share capital of Krux Pharma Private Limited is ₹ 3.00 Cr and paid-up capital is ₹ 3.00 Cr.
Who are the current board members & directors of Krux Pharma Private Limited?
Currently 2 directors are associated with Krux Pharma Private Limited.
- Salim Diwan Salaudeen Chopdar
- Imran Shabbir Hussain Siroha
What is the registered address of Krux Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Krux Pharma Private Limited is Plot No. 10 11 Survey 256/P1 Nr. Balda Industrial Parkvillage Balda, Ta. Pardi India, Valsad, Gujarat, 396125.
What is the corporate identification number (CIN) and company number of Krux Pharma Private Limited?
The corporate identification number (CIN) of Krux Pharma Private Limited is U24302GJ2016PTC094103 and the company number is 094103 as per Ministry of Corporate Affairs (MCA).
What is the official website of Krux Pharma Private Limited?
The Official website of Krux Pharma Private Limited is https://www.kruxpharma.com
What has been the recent revenue trend for Krux Pharma Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Krux Pharma Private Limited has risen by 45.11%.
How many employees does Krux Pharma Private Limited currently have?
As Per 2024 financial reports, 42 employees are currently employed by Krux Pharma Private Limited.
What change has been observed in the net worth of Krux Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Krux Pharma Private Limited has experienced an upsurge of 2.42%.
What are the total open charges for Krux Pharma Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Krux Pharma Private Limited amount to ₹ 11.77 Cr.
When was the last Balance Sheet of Krux Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Krux Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
DZ
Digambar ZawarDirectorMC
Mahboob ChopdarDirector